Anthony Mancini files SEC Form 4 disclosures for Revolution Medicines, Inc.. They have made 1 open-market trade across 1 company since 2026, most recently 2026-09-25.
CIK 0002124509
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RVMD | 39,765 | $7.1M |
Shares reported on the most recent Form 4, priced at the 2026-09-28 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RVMD | SELL · 10b5-1 | 2026-09-24 | 2026-09-28 | $200.45 | $743K | -6.9% | — | — |
| RVMD | SELL · 10b5-1 | 2026-09-18 | 2026-09-22 | $196.94 | $347K | +6.7% | — | — |
| RVMD | SELL · 10b5-1 | 2026-09-16 | 2026-09-18 | $199.24 | $353K | +6.8% | — | — |
| RVMD | SELL · 10b5-1 | 2026-09-10 | 2026-09-14 | $204.16 | $3.2M | -3.2% | -6.1% | — |
| RVMD | SELL | 2026-06-16 | 2026-06-18 | $156.12 | $720K | +15.5% | +11.1% | +20.8% |
| RVMD | SELL · 10b5-1 | 2026-05-26 | 2026-05-28 | $153.99 | $481K | -3.6% | +24.1% | +38.6% |
| RVMD | SELL · 10b5-1 | 2026-04-27 | 2026-04-29 | $132.41 | $413K | +0.6% | +10.0% | +28.3% |
| RVMD | SELL · 10b5-1 | 2026-03-25 | 2026-03-26 | $95.56 | $7.2M | +3.8% | +41.3% | +82.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.